Cargando…
The pivotal role of mammalian target of rapamycin inhibition in the treatment of patients with neuroendocrine tumors
Significant advances have been made toward understanding the biology of neuroendocrine tumors (NET) in terms of defining prognosis and improving clinical management; however, many unmet needs remain. The treatment landscape for NET has evolved, with the approval of the targeted agents everolimus and...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5083749/ https://www.ncbi.nlm.nih.gov/pubmed/27539383 http://dx.doi.org/10.1002/cam4.742 |